Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period

Completed · Phase 3 · Has a placebo group

Conditions studied: Prader-Willi Syndrome

In brief

This is a multi-center, multi-period study with an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period evaluating the safety and efficacy of DCCR treatment.

Key facts

Study ID
NCT03714373
Run by
Soleno Therapeutics, Inc.
People needed
115
Starts
2018-10-01
Expected to finish
2023-08-17
Last updated by the study team
2024-04-19

Who can join

Age: 4 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.